SCHEMBL5899481

SCHEMBL5899481

CC(C)(C)c1ccc(S(=O)(=O)NCC(=O)c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
NPC1 O15118 1/20 0.56
RECQL P46063 1/20 0.56
RAB9A P51151 1/20 0.56
HDAC3 O15379 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
KAT6A Q92794 2/20 0.52
MAPT P10636 2/20 0.52
LMNA P02545 3/20 0.50
MMP1 P03956 1/20 0.50
GAA P10253 1/20 0.50
MMP12 P39900 1/20 0.50
UQCRB P14927 1/20 0.49
HSD17B2 P37059 1/20 0.49
HTT P42858 1/20 0.48
CYP2C19 P33261 1/20 0.48
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899544 0.85 KAT6A (0.58) ALDH1A1MEN1KMT2AHDAC8HDAC6
SCHEMBL5899469 0.84 ALDH1A1 (0.66) ALDH1A1MEN1KMT2ANPC1RECQL
SCHEMBL5320466 0.84 ALDH1A1 (0.60) ALDH1A1MEN1KMT2ANPC1RECQL
SCHEMBL23014361 0.81 KAT6A (0.58) ALDH1A1MEN1KMT2AKAT6ALMNA
SCHEMBL5899482 0.81 L3MBTL1 (0.60) ALDH1A1MEN1KMT2AKAT6AMAPT
SCHEMBL5899737 0.81 MMP1 (0.63) ALDH1A1MEN1KMT2AKAT6AMAPT
SCHEMBL5899468 0.80 MEN1 (0.67) ALDH1A1MEN1KMT2AHDAC3HDAC8
SCHEMBL5899447 0.78 MMP2 (0.70) ALDH1A1KAT6ALMNAMMP1GAA
SCHEMBL5899480 0.77 KAT6A (0.54) ALDH1A1MEN1KMT2ANPC1RECQL
SCHEMBL268855 0.76 RAB9A (0.73) ALDH1A1MEN1KMT2ANPC1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 ALDH1A1 139/4885MEN1 1269/4885KMT2A 1509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.